Primary Hypothyroidism Requiring Levothyroxine Treatment
This pattern of elevated TSH with low FT4 and low FT3 indicates overt primary hypothyroidism, and you should initiate levothyroxine (L-thyroxine) replacement therapy immediately 1.
Interpretation
The biochemical pattern represents manifest primary hypothyroidism where:
- The thyroid gland is failing (low FT4 and FT3 production)
- The pituitary appropriately responds by increasing TSH secretion
- This distinguishes it from central hypothyroidism (where TSH would be low or inappropriately normal) 2
Important caveat: Before starting treatment, rule out adrenal insufficiency in at-risk patients, as thyroid hormone replacement can precipitate adrenal crisis. Those with suspected adrenal insufficiency should receive hydrocortisone first until adrenal function is confirmed normal 1.
Management Algorithm
Starting Dose Selection
For patients under 50-60 years without coronary heart disease:
- Start full replacement dose: 1.6 mcg/kg/day of levothyroxine
- Can begin with standard doses (typically 75-100 mcg daily)
For patients over 50-60 years OR with known coronary disease:
- Age >50-60 without CHD: Start 50 mcg daily 1
- Known coronary disease: Start 12.5-25 mcg daily 1
- Monitor closely for anginal symptoms, which may limit achieving full euthyroidism
Elderly patients require 20-25% less levothyroxine per kilogram than younger patients due to decreased lean body mass, despite less efficient absorption 1.
Monitoring and Dose Adjustment
- Recheck TSH and FT4 in 4-8 weeks after starting treatment
- Continue checking every 4-8 weeks until TSH stabilizes in normal range on consistent dose 1
- Target TSH: 0.4-4.0 mIU/L (some experts prefer 0.4-2.5 mIU/L) 1, 2
Administration Instructions
- Take levothyroxine on empty stomach, ideally 30-60 minutes before breakfast
- Absorption is significantly diminished by meals and competing medications 1
- If doses are missed, make them up when recognized, even if on the same or subsequent day
- For severe compliance issues, weekly dosing is an acceptable alternative 1
Critical Pitfalls to Avoid
Overtreatment occurs in 20% of patients and causes serious consequences 1:
- Cardiovascular risks: atrial fibrillation (especially elderly), increased cardiovascular events
- Skeletal risks: accelerated bone loss (especially postmenopausal women)
- Neuropsychiatric effects: affective disturbances
Do not use FT3 levels as therapeutic endpoints - T3 may remain in the lower reference range or even mildly subnormal despite adequate treatment when TSH normalizes 1. This is physiologically normal and does not indicate undertreatment.
If TSH remains elevated on high doses (>200 mcg/day):
- First suspect non-compliance (most common cause) 1
- Then evaluate for absorption problems (medications, gastrointestinal disorders)
- Consider weekly supervised dosing if compliance is the issue
Special Considerations
Before surgery: Elective procedures should wait until euthyroid state achieved, though emergency coronary bypass can be safely performed while still hypothyroid 1.
Pregnancy: If this occurs in a woman of childbearing age, increase levothyroxine dose by 30-50% immediately if pregnancy occurs, as requirements increase substantially 1.